Free Trial
→ Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (From Behind the Markets) (Ad) Buy BBIO Stock  Free BBIO Stock Alerts

BridgeBio Pharma (BBIO) SEC Filings & 10K Form

BridgeBio Pharma logo
$33.34 +0.37 (+1.12%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$34.65 +1.31 (+3.93%)
As of 05/23/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent BridgeBio Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
05/20/2025
5:06 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:05 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:07 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
3:25 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
4:24 PM		BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:52 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SCHEDULE 13D/A
05/12/2025
8:46 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
5:00 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
3:40 PM		BridgeBio Pharma (Filer)
Form DEFA14A
05/06/2025
3:42 PM		BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
3:45 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
5:01 AM		BridgeBio Pharma (Filer)
Form DEF 14A
04/30/2025
5:02 AM		BridgeBio Pharma (Filer)
Form ARS
04/16/2025
4:39 PM		BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:06 PM		BridgeBio Pharma (Filer)
Form PRE 14A
04/14/2025
3:21 PM		BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2025
4:11 PM		BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:48 PM		BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
3:54 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:32 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:09 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:03 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:28 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SCHEDULE 13D/A
03/10/2025
3:43 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:09 PM		BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:15 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SCHEDULE 13D/A
03/06/2025
3:06 PM		BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
8:09 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
7:22 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
4:36 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
3:35 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
6:31 AM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:48 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:50 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:51 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:31 PM		BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:31 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
4:23 PM		BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
Form SCHEDULE 13G/A
01/31/2025
6:18 PM		BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
6:18 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
6:18 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SCHEDULE 13D/A
Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)

A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.

Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks.
01/30/2025
5:29 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:31 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
3:18 PM		BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
3:18 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
3:53 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:43 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4/A
12/31/2024
4:52 PM		BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
6:18 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
6:05 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:16 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
6:57 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
7:00 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:06 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:13 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:15 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
3:24 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:44 AM		BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
Form SC 13G/A
11/06/2024
4:04 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
10/22/2024
5:06 PM		BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
Form SC 13G/A
09/17/2024
5:44 PM		BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:41 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SC 13D/A
09/13/2024
4:04 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:16 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
7:42 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
08/20/2024
5:24 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:27 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:31 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:27 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:29 PM		BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
3:39 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:06 PM		BridgeBio Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
6:31 AM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
7:16 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/23/2024
3:12 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:38 PM		BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:38 PM		BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM		BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM		BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM		BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:40 PM		BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:42 PM		BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:42 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:34 PM		AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:35 PM		BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:36 PM		BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:36 PM		BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump Predicts Dollar Downfall (Ad)

READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?

Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now.
06/06/2024
5:01 AM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:53 PM		BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BBIO) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...
Brownstone Research | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored